Search results for "Cancer"

showing 10 items of 11546 documents

Selected Age-Related Disorders

2013

Aged human individuals are frequently affected by various age-related impairments and disorders at once (multimorbidity) making it difficult to investigate and understand the link between aging as key risk factor and single syndromes. In some chapters of this book links have been identified between molecular mechanisms of aging and the pathogenesis of human disorders in the elderly. Here, the focus is put on Alzheimers disease (AD) and cancer. While cancer in many cases can successfully be treated and sometimes even cured by pharmacology and/or surgery, AD is still an incurable deadly disease. Like almost no other disorder the onset of AD is strictly associated with higher age and experienc…

medicine.medical_specialtybusiness.industryCancerContext (language use)Aging societyDiseasemedicine.diseaseAge relatedmedicineRisk factorAlzheimer's diseasePsychiatrybusinessBrain aging
researchProduct

Hepatocellular carcinoma: one world, one cancer—different guidelines?

2018

Hepatocellular carcinoma (HCC) is a healthcare challenge in virtually all parts of the world. Therefore, it is no wonder that different guidelines have been developed reflecting expert consensus on the management of HCC in different regions, namely guidelines from the American Association for the Study of Liver Diseases (AASLD) for the USA (1,2), the Asian Pacific Association for the Study of the Liver (APASL) for the Asia-Pacific region (3), the European Association for the Study of the Liver (EASL) for Europe (4), and the Japan Society of Hepatology (JSH) for Japan (5,6). In 2018 an update of the EASL clinical practice guidelines (CPG) will appear.

medicine.medical_specialtybusiness.industryCancerExpert consensusHepatologymedicine.diseaseClinical Practice03 medical and health sciences0302 clinical medicineEditorial030220 oncology & carcinogenesisHepatocellular carcinomaFamily medicineInternal medicinemedicine030211 gastroenterology & hepatologybusiness
researchProduct

Reply

2017

medicine.medical_specialtybusiness.industryCancerGold standard (test)030230 surgerymedicine.diseaseSurgery03 medical and health sciences0302 clinical medicineLymphedema030220 oncology & carcinogenesisLymph flowmedicineSurgeryRadiologybusinessReliability (statistics)Plastic and Reconstructive Surgery
researchProduct

Concomitant history of cancer in acute pulmonary embolism is connected with poorer outcome

2015

Abstract Purpose: Cancer increases the risk of venous thromboembolism (VTE) substantially. VTE is connected with poorer outcome in cancer patients. The aim of our study was to investigate the impact of cancer on the severity and short-term outcome of pulmonary embolism (PE). Methods: We retrospectively analyzed the data of 182 patients with confirmed PE. PE patients were subdivided in the group with concomitant active cancer disease or history of cancer or in the group without cancer. Groups were compared with Wilcoxon–Mann–Whitney Test. Logistic regression models were calculated to investigate the association between cancer and several parameters such as age and PE severity status as well …

medicine.medical_specialtybusiness.industryCancerHematologyV q scanDiseasemedicine.diseaseLogistic regressionPulmonary embolismSurgeryOncologyInternal medicineConcomitantTroponin ImedicinebusinessVenous thromboembolismActa Haematologica Polonica
researchProduct

Biomarker testing of lung cancer in Spain

2019

Abstract Background Target therapy guide by biomarkers have become the standard of care for patients with lung cancer (LC). So, identify those molecular alterations is one of the most important care needs nowdays. Our objective was to know the implementation degree of these tests in a large cohort of patients in Spain using the Thoracic Tumor Registry (TTR) of the Grupo Espanol de Cancer de Pulmon (Spanish Lung Cancer Group). Methods The TTR is an observational cohort multicenter study of LC in Spain. The study is conducted according to the Declaration of Helsinki and approved by the institutional review board of each participating institute. The registry was approved by the Spanish Drug Ag…

medicine.medical_specialtybusiness.industryCancerHematologymedicine.diseaseInstitutional review boardHelsinki declarationClinical trialOncologyInternal medicineCohortmedicineBiomarker (medicine)Lung cancerbusinessGeographic differenceAnnals of Oncology
researchProduct

Out-of-pocket costs in gastrointestinal cancer patients: Lack of a perfectly framed problem contributing to financial toxicity

2021

Abstract Fighting cancer is an economically expensive challenge for both health care payers, and the patients and their families and the median costs for cancer care are rapidly increasing in the last decade. Although both direct and indirect costs of medical assistance have been a frequent source of distress and contention, however analysis of the non-medical expenses incurred directly by cancer patients has not received adequate attention. Developing a deeper understanding of so-called "out-of-pocket" costs may be necessary. Out-of-pocket costs for medical care range from 7 % to 11 % of medical costs for all payers. However, the range of out-of-pocket costs shows considerable variability …

medicine.medical_specialtybusiness.industryCancerHematologymedicine.diseaseMedical careDistressIndirect costsCost of IllnessOncologyHealth caremedicineHumansPatient CareGastrointestinal cancerHealth ExpendituresbusinessIntensive care medicineMedical costsPsychosocialhealth care economics and organizationsGastrointestinal NeoplasmsCritical Reviews in Oncology/Hematology
researchProduct

EP1168 The influence of obesity on tumor recurrence in vulvar cancer patients

2019

Introduction/Background Obesity is associated with decrased survival in several cancer entities. The influence of obesity on prognosis of vulvar cancer patients is not clear. However, knowledge about this may have consequences on treatment and follow-up. Methodology This is an analysis of the large AGO-CaRE-1 study which included vulvar cancer patients (UICC stage IB and higher), treated in 29 cancer centers between 1998 and 2008, in order to analyze treatment patterns and prognostic factors. Results In total, 849 eligible patients were divided into two groups depending on their body mass index (BMI, 0.05). Radical vulvectomies were performed more frequently in patients having a BMI ≥30 kg/…

medicine.medical_specialtybusiness.industryCancerSubgroup analysisVulvar cancermedicine.diseaseObesityTumor recurrenceTime to recurrenceInternal medicineMedicineIn patientbusinessBody mass indexePoster
researchProduct

Impact of surgeon organization and specialization in rectal cancer outcome.

2001

Purpose The present study was designed to assess the differences in the outcome of patients with rectal cancer treated by a group of surgeons before and after being organized as a Coloproctology Unit at the same University Department of Surgery. Methods Comparison of two periods of rectal cancer surgery: I (1986–91) and II (1992–95). Period I: 94 patients were operated on by 14 general surgeons. Period II: 108 patients were operated on by only 4 surgeons of the same group organized as a Colorectal Surgery Unit after visiting referral centres abroad, adopting techniques such as total mesorectal excision (TME) for middle and low rectal cancer and washout of rectal stump. Mean follow-up during…

medicine.medical_specialtybusiness.industryColorectal cancerAbdominoperineal resectionGastroenterologyProspective datamedicine.diseaseTotal mesorectal excisionColorectal surgerySurgeryLog-rank testLow rectal cancerRectal cancer surgeryMedicinebusinessColorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
researchProduct

Can we set quality standards for the centers : minimally invasive surgery vs. open surgery in colorectal cancer resection

2020

Esta comunicación se encuentra disponible en la siguiente URL: https://www.fortunejournals.com/articles/can-we-set-quality-standards-for-the-centers-minimally-invasive-surgery-vs-open-surgery-in-colorectal-cancer-resection.pdf Background: Minimally invasive surgery (MIS) is the standard method for resection of colorectal cancer, but its indications have limitations that are constantly debated. In our study, the center had to meet the following four factors: surgeons should have considerable experience, there should be a high percentage of MIS, a low conversion rate, and good results in the intervention. Methods: Retrospective observational study of a cohort of 948 patients with colorectal c…

medicine.medical_specialtybusiness.industryColorectal cancerOpen surgerymedia_common.quotation_subjectGeneral surgerySurgery Operative.Colon - Cáncer - Cirugía.medicine.diseaseColon (Anatomy) - Cancer - Surgery.ResectionInvasive surgeryMedicineQuality (business)Cirugía operatoria.businessmedia_common
researchProduct

A multimodality approach to localized rectal cancer.

2006

medicine.medical_specialtybusiness.industryColorectal cancerRectal NeoplasmsHematologymedicine.diseaseCombined Modality TherapyNeoadjuvant TherapyMultimodalityText miningOncologyMedicineHumansRadiologybusinessAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct